Worldwide obesity has more than doubled in the last 25 years; in 2014 over 600 million adults were obese according to statistics provided by the World Health Organization (WHO). The increasing incidence of obesity in both developed and developing countries is proving a considerable challenge to anaesthesia departments.
Obese patients undergoing surgery typically have associated risks, complications and comorbidities. As a result, anaesthesia machines with advanced performance levels are required. Such machines offer increased functionality including high flow, high pressure and extended range parameters, allowing the machine to be used across the full patient spectrum.
Despite the increasing need for high-performance anaesthesia machines, the current economic environment is conflicting opinion. Healthcare providers face a price, performance ratio; the price is often a determining factor over the performance of the anaesthesia machine.
With the incidence of obesity set to continue to increase, will the importance of high-performance anaesthesia machines be realized, and will these benefits outweigh the continuing price pressure on the healthcare market?